Beta Bionics director Adam Lezack sells 1,998 common shares for $21,112.58
PUBT · 05/26 22:01
Share
Listen to the news
- Beta Bionics director Adam Lezack reported sales of 1,998 common shares at USD 9.95 and USD 11.21 on May 21-22.
- He also reported acquiring 16,965 common shares at USD 0 on May 21 via a restricted stock unit award.
- Lezack’s direct holding rose to 27,399 common shares following the transactions.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Beta Bionics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0002048466-26-000003), on May 26, 2026, and is solely responsible for the information contained therein.
Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending